Clinical Trial Update: Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Tasca Therapeutics is testing CP-383 in a Phase 1/2 trial for patients with advanced or metastatic solid tumors, including colorectal cancer, small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Pancreatic Cancer
• Small Cell Lung Cancer

Drugs mentioned

• CP-383

Snippet

Sponsor: Tasca Therapeutics | Conditions: Solid Tumor Malignancies, Colorectal Carcinoma | Phase 1, Phase 2 | Status: RECRUITING